PatchSiren

PatchSiren cyber security CVE debrief

CVE-2026-6371 Limatek System Inc. CVE debrief

CVE-2026-6371 is a Stored XSS vulnerability in Limatek System Inc. LimRAD NAC through version 08072026. The vulnerability allows an attacker to inject malicious scripts into the web application, which can then be executed by other users. Users should review and apply patches or mitigations provided by the vendor. The issue has a CVSS score of 4.8 and is considered Medium severity.

Vendor
Limatek System Inc.
Product
LimRAD NAC
CVSS
MEDIUM 4.8
CISA KEV
Not listed in stored evidence
Original CVE published
2026-07-08
Original CVE updated
2026-07-20
Advisory published
2026-07-08
Advisory updated
2026-07-20

Who should care

Users of Limatek System Inc. LimRAD NAC through version 08072026 should review and apply the necessary patches or mitigations. Operators, administrators, and security teams responsible for LimRAD NAC deployments should assess their exposure and take action.

Technical summary

CVE-2026-6371 is a Stored XSS vulnerability in Limatek System Inc. LimRAD NAC through version 08072026. The vulnerability allows an attacker to inject malicious scripts into the web application, which can then be executed by other users. This could lead to user-impacting attacks. The issue affects LimRAD NAC through version 08072026. Users should review system configurations, verify for exposed systems, and monitor for suspicious activity. Defenders should confirm whether affected product deployments exist in managed environments and assign an owner for follow-up. The CVE record was published on 2026-07-08T12:17:20.780Z and has not been modified since then.

Defensive priority

Medium priority due to CVSS score of 4.8 and potential for user-impacting attacks.

Recommended defensive actions

  • Review and apply patches or mitigations provided by the vendor.
  • Implement input validation and output encoding for user-supplied data.
  • Monitor for suspicious activity and implement compensating controls as needed.
  • Confirm whether affected product deployments exist in managed environments and assign an owner for follow-up.
  • Review the supplied official advisory or CVE record to validate affected scope, severity, and vendor guidance.
  • Plan vendor-supported updates or mitigations through normal change control where exposure is confirmed.
  • Check relevant monitoring, detection, and logs for exposed assets that need extra review.

Evidence notes

The CVE record was published on 2026-07-08T12:17:20.780Z and has not been modified since then. The NVD entry is currently Deferred. Evidence is limited to CVE and NVD information. Defenders should verify system configurations, review for exposed systems, and monitor for suspicious activity.

Sources and references

Verified primary and authoritative sources

  • CVE-2026-6371 CVE Program record

    Publisher, destination, and source semantics verified

    URL: https://www.cve.org/CVERecord?id=CVE-2026-6371

    CVE Program - Official CVE Program record with source-provided CVE metadata.

  • CVE-2026-6371 NVD vulnerability detail

    Publisher, destination, and source semantics verified

    URL: https://nvd.nist.gov/vuln/detail/CVE-2026-6371

    NIST National Vulnerability Database - Official NIST NVD detail page and source-specific vulnerability assessment.

Supplemental references

Methodology and review provenance

AI-assisted synthesis based on stored public vulnerability evidence. System validation, approval state, and publication status do not by themselves establish human review of this revision. PatchSiren helps prioritize defensive review and does not prove exposure or remediation on any system.